Page 14 - A. Aging
P. 14

[A. Aging-8]



                       CD9 induces cellular senescence and aggravates


                                   atherosclerotic plaque formation




               Eok-Cheon Kim¹˙²˙#, Youlim Son¹˙²˙#, Jung Hee Cho¹˙²˙#, Da-Woon Lee¹˙², Yong Seop Park¹˙²,

                          Jun-Hyuk Choi³, Kyung-Hyun Cho⁴, Ki-Sun Kwon⁵, Jae-Ryong Kim¹˙²˙*


          ¹Department of Biochemistry and Molecular Biology, College of Medicine, Yeungnam University, Daegu 42415,
         Republic of Korea, ²Smart-aging Convergence Research Center, College of Medicine, Yeungnam University, Daegu

          42415, Republic of Korea, ³Department of Pathology, College of Medicine, Yeungnam University, Daegu 42415,

         Republic of Korea, ⁴School of Biotechnology, Yeungnam University, Gyeongsan 38541, Republic of Korea, ⁵Aging
          Research Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea




        CD9 is known to regulate cell adhesion and migration, cancer progression and metastasis, immune and allergic

        responses,  and  viral  infection.  CD9  is  upregulated  in  senescent  endothelial  cells,  neointima  hyperplasia,  and
        atherosclerotic  plaques.  However,  its  role  in  cellular  senescence and atherosclerosis remains undefined. We

        investigated the potential mechanism for CD9-mediated cellular senescence and its role in atherosclerotic plaque
        formation.  CD9  knockdown  in  senescent  HUVECs  significantly  rescued  senescence  phenotypes,  while  CD9

        upregulation  in  young  cells  accelerated  senescence.  CD9  regulated  cellular  senescence  through  a
        phosphatidylinositide 3 kinase-AKT-mTOR-p53 signal pathway. CD9 expression increased in arterial tissues from

        humans and rats with age, and in atherosclerotic plaques in humans and mice. Anti-mouse CD9 antibody noticeably
        prevented the formation of atherosclerotic lesions in ApoE-/- mice and Ldlr-/- mice. Furthermore, CD9 ablation in

        ApoE-/- mice decreased atherosclerotic lesions in aorta and aortic sinus. These results suggest that CD9 plays
        critical roles in endothelial cell senescence and consequently the pathogenesis of atherosclerosis, implying that CD9
        is a novel target for prevention and treatment of vascular aging and atherosclerosis.
   9   10   11   12   13   14   15   16   17   18   19